• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Influenza

Xofluza
Pharma

Roche signs generic Xofluza licensing deal with MPP

Under the Roche deal, MPP is seeking applications from generic makers that have the capacity to support the development and supply of generic Xofluza.
Angus Liu May 19, 2026 11:15am
Robert F Kennedy Jr US President Donald Trumps nominee for Secretary of Health and Human Services testifies during hi

RFK Jr., CDC targeted in suit from 15 states over vaccine policy

Feb 25, 2026 8:30am
The exterior of the Centers for Disease Control and Prevention campus in Chamblee Georgia March 18 2025

CDC removes US recommendations for 6 of 17 childhood vaccines

Jan 5, 2026 5:26pm
CSL Seqirus CSL plant Melbourne Australia CSL Seqiris plant flu shot plant influenza

Its future murky, CSL Seqirus opens $1B vax plant in Australia

Dec 9, 2025 9:08am
yellow light street light traffic pause slow delay

CSL delays vax unit spinoff as US immunization rates plummet

Oct 28, 2025 10:00am
flu immune system virus influenza COVID infection

Cidara snares BARDA award to boost R&D, production of flu asset

Oct 3, 2025 10:10am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings